Insider Trading History of Talevich James R

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Talevich James R since 2006. The trader's CIK number is 1243895. At the time of the last reporting, Talevich James R was the Chief Financial Offi of Biolase, Inc. (stock ticker symbol BIOL). Also see all insider trading activities at Biolase, Inc.

Note that in the past TALEVICH JAMES R also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Biolase, Inc (BIOL) by Talevich James R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2018 BIOL 0 $0 0 $0 7,394 $0
2017 BIOL 0 $0 0 $0 52,500 $0
2015 BIOL 0 $0 0 $0 9,217 $0

Yearly summary of insider trading at I Flow Corp /de/ (IFLO) by Talevich James R

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2008 IFLO 0 $0 0 $0 2,025 $23,328
2007 IFLO 0 $0 22,456 $450,987 0 $0
2006 IFLO 0 $0 2,179 $31,922 17,635 $81,177


Insider trading activities at 2 companies by Talevich James R:

1. Biolase, Inc (BIOL)

2. I Flow Corp /de/ (IFLO)

Table 1. Insider trading of Biolase, Inc (BIOL) by Talevich James R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2018-05-11 BIOL Option Ex 7,394 .00 0
2017-05-08 BIOL Option Ex 52,500 .00 0
2015-08-27 BIOL Option Ex 9,217 .00 0

Table 2. Insider trading of I Flow Corp /de/ (IFLO) by Talevich James R

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2008-11-14 IFLO Option Ex 2,025 11.52 23,328
2007-08-10 IFLO Sale 9,456 19.95 188,647
2007-08-09 IFLO Sale 13,000 20.18 262,340
2006-12-14 IFLO Option Ex 2,179 2.91 6,340
2006-12-14 IFLO Sale 2,179 14.65 31,922
2006-07-27 IFLO Option Ex 15,456 4.84 74,837

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Talevich James R (Chief Financial Offi of Biolase, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.